Molecular Regulation of Cardiac Chamber-Specific Gene Expression

Trends in Cardiovascular Medicine

Volumn 14, Issue 1, 2004, Pages 13-18

  Small, Eric M ^a   Krieg, Paul A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CALCIUM BINDING PROTEIN; CONNEXIN 40; HOMEODOMAIN PROTEIN; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 3; MYOSIN LIGHT CHAIN; MYOSIN LIGHT CHAIN 2ALPHA; MYOSIN LIGHT CHAIN 2V; PROTEIN IRX4; SARCOLIPIN; UNCLASSIFIED DRUG;

GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC REGULATION; HEART ATRIUM; HEART DEVELOPMENT; HEART VENTRICLE; HUMAN; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SHORT SURVEY;

EID: 0346056964     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2003.09.005     Document Type: Review

References (43)

1. Bao Z-Z, Bruneau B.G., Seidman JGet al. Regulation of chamber-specific gene expression in the developing heart by Irx4. Science. 283:1999;1161-1164.
2. Bruneau B.G., Bao Z-Z, Tanaka Met al. Cardiac expression of the ventricle-specific homeobox gene Irx4 is modulated by Nkx2-5 and dHand. Dev Biol. 217:2000;266-277.
3. Bruneau B.G., Bao Z.Z., Fatkin Det al. Cardiomyopathy in Irx4-deficient mice is preceded by abnormal ventricular gene expression. Mol Cell Biol. 21:2001;1730-1736.
4. Bruneau B.G., Nemer G., Schmitt JPet al. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell. 106:2001;709-721.
5. Chen J., Kubalak S.W., Chien K.R. Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development. 125:1998;1943-1949.
6. Chen J., Kubalak S.W., Minamisawa Set al. Selective requirement of myosin light chain 2v in embryonic heart function. J Biol Chem. 273:1998;1252-1256.
7. Delorme B., Dahl E., Jarry-Guichard Tet al. Developmental regulation of connexin 40 gene expression in mouse heart correlates with the differentiation of the conduction system. Dev Dyn. 204:1995;358-371.
8. -/- mice. Proc Natl Acad Sci USA. 92:1995;7386-7390.
9. Durocher D., Chen C.Y., Ardati Aet al. The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium. Mol Cell Biol. 16:1996;4648-4655.
10. Edmondson D.G., Lyons G.E., Martin J.F., Olson E.N. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development. 120:1994;1251-1263.
11. Field L.J. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science. 239:1988;1029-1033.
12. Gardner D.G., Deschepper C.G., Ganong WFet al. Extra-atrial expression of the gene for atrial natriuretic factor. Proc Natl Acad Sci USA. 83:1986;6697-6701.
13. Habets PEMH, Moorman A.F.M., Clout DEWet al. Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev. 16:2002;1234-1246.
14. Hailstones D., Barton P., Chan-Thomas Pet al. Differential regulation of the atrial isoforms of myosin light chains during striated muscle development. J Biol Chem. 267:1992;23,295-23,300.
15. Henderson S.A., Spencer M., Sen Aet al. Structure, organization, and expression of the rat cardiac myosin light chain-2 gene: identification of a 250 bp fragment which confers cardiac specific expression. J Biol Chem. 264:1989;18,142-18,148.
16. Houweling A.C., Somi S., Van Den Hoff MJet al. Developmental pattern of ANF gene expression reveals strict localization of cardiac chamber formation in chicken. Anat Rec. 266:2002;93-102.
17. Kastner P., Grondona J.M., Mark Met al. Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell. 78:1994;987-1003.
18. Knowlton K.U., Rockman H.A., Itani Met al. Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium. J Clin Invest. 96:1995;1311-1318.
19. Koss K.L., Ponniah S., Jones WKet al. Differential phospholamban gene expression in murine cardiac compartments. Circ Res. 77:1995;342-353.
20. Kubalak S.W., Miller-Hance W.C., O'Brien TXet al. Chamber specification of atrial myosin light chain-2 expression precedes septation during murine cardiogenesis. J Biol Chem. 269:1994;16,961-16,970.
21. Lee K.J., Ross R.S., Rockman HAet al. Myosin light chain-2 luciferase transgenic mice reveal distinct regulatory programs for cardiac and skeletal muscle-specific expression of a single contractile protein gene. J Biol Chem. 267:1992;15,875-15,885.
22. Minamisawa S., Wang Y., Chen Jet al. Atrial chamber-specific expression of sarcolipin is regulated during development and hypertrophic remodeling. J Biol Chem. 278:2003;9570-9575.
23. Navankasattusas S., Zuh H., Garcia Aet al. A ubiquitous factor (HF-1a) and a distinct muscle factor (HF-1b/MEF-2) form an E-box independent pathway for cardiac muscle gene expression. Mol Cell Biol. 12:1992;1469-1479.
24. Nguyen-Tran V.T.B., Chen J., Ruiz-Lozano P., Chien K.R. The MLC-2 paradigm for ventricular heart chamber specification, maturation, and morphogenesis. Harvey R.P., Rosenthal N. Heart development. 1999;255-272 Academic Press, San Diego, CA.
25. Nikovits W. Jr., Wang G.F., Feldman J.L. Isolation and characterization of an avian slow myosin heavy chain gene expressed during embryonic skeletal muscle fiber formation. J Biol Chem. 271:1996;17,047-17,056.
26. O'Brien T.X., Lee K.J., Chien K.R. Positional specification of ventricular myosin light chain 2 expression in the primitive murine heart tube. Proc Natl Acad Sci USA. 90:1993;5157-5161.
27. Ross R.S., Navansakasattusas S., Harvey R.P., Chien K.R. An HF-1a/HF-1b/MEF-2 combinatorial element confers cardiac ventricular specificity and establishes an anterior-posterior gradient of expression. Development. 122:1996;1799-1809.
28. Seidman C.E., Schmidt E.V., Seidman J.G. Cis-dominance of rat atrial natriuretic factor gene regulatory sequences in transgenic mice. Can J Physiol Pharmacol. 69:1991;1486-1492.
29. Small E.M., Krieg P.A. Expression of atrial natriuretic factor (ANF) during Xenopus cardiac development. Dev Genes Evol. 210:2000;638-640.
30. Small E.M., Krieg P.A. Transgenic analysis of the atrial natriuretic factor (ANF) promoter: Nkx2-5 and GATA-4 binding sites are required for atrial specific expression of ANF. Dev Biol. 261:2003;116-131.
31. Sucov H.M., Dyson E., Gumeringer CLet al. RxRa mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 8:1994;1007-1018.
32. Takimoto E., Mizuno T., Terasaki Fet al. Up-regulation of natriuretic peptides in the ventricle of Csx/Nkx2-5 transgenic mice. Biochem Biophys Res Commun. 270:2000;1074-1079.
33. Van Kempen M.J.A., Vermeulen J.L.M., Moorman AFMet al. Developmental changes of connexin40 and connexin43 mRNA distribution patterns in the rat heart. Cardiovasc Res. 32:1996;886-900.
34. Wang G.F., Stockdale F.E. Chamber-specific gene expression and regulation during heart development. Harvey R.P., Rosenthal N. Heart development. 1999;357-369 Academic Press, San Diego, CA.
35. Wang G.F., Nikovits W., Schleinitz M., Stockdale F.E. Atrial chamber-specific expression of the slow myosin heavy chain 3 gene in the embryonic heart. J Biol Chem. 271:1996;19,836-19,845.
36. Wang G.F., Nikovits W. Jr., Schleinitz M., Stockdale F.E. A positive GATA element and a negative vitamin D receptor-like element control atrial chamber-specific expression of a slow myosin heavy-chain gene during cardiac morphogenesis. Mol Cell Biol. 18:1998;6023-6034.
37. Wang G.F., Nikovits W. Jr., Bao Z.Z., Stockdale F.E. Irx4 forms an inhibitory complex with the vitamin D and retinoic X receptors to regulate cardiac chamber-specific slow MyHC3 expression. J Biol Chem. 276:2001;28,835-28,841.
38. Yutzey K.E., Rhee J.T., Bader D. Expression of the atrial-specific myosin heavy chain AMHC1 and the establishment of anteroposterior polarity in the developing chicken heart. Development. 120:1994;71-83.
39. Zammit P.S., Kelly R.G., Franco Det al. Suppression of atrial myosin gene expression occurs independently in the left and right ventricles of the developing mouse heart. Dev Dyn. 217:2000;75-85.
40. Zeller R., Bloch K.D., Williams BSet al. Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis. Genes Dev. 1:1987;693-698.
41. Zhu H., Garcia S., Ross RSet al. A conserved 28 bp element (HF-1) within the rat cardiac myosin light chain-2 gene confers cardiac specific and a-adrenergic inducible expression in cultured neonatal rat myocardial cells. Mol Cell Biol. 11:1991;2273-2281.
42. Zou Y., Chien K.R. EFIA/YB-1 is a component of cardiac HF-1A binding activity and positively regulates transcription of the myosin light chain-2 v gene. Mol Cell Biol. 15:1995;2972-2982.
43. Zou Y., Evans S., Chen Jet al. CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. Development. 124:1997;793-804.